Concepedia

Chao Lin

CL

31

Publications

5.4K

Citations

24

H-Index

1993

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Washington University in St. Louis

Yunnan University

The University of Queensland

Chao Lin is an author at Vertex Pharmaceuticals (United States) specializing in medicine, virology, and hepatitis.

Top concepts

MedicineVirologyHepatitisMolecular BiologyViral HepatitisNatural SciencesImmunologyBiochemistryEngineeringPathogenesis

Publications per year

1993–2016

31

Publications

31

Expression and identification of hepatitis C virus polyprotein cleavage products

Arash Grakoui, Czeslaw Wychowski, Chao Lin et al. · Journal of Virology · 1993 · 882 citations · Full text

Ns2-specific Hcv Antisera, Virus Structure, Hcv Polyprotein Processing +14

Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide

J.L Kim, Kurt Morgenstern, Chao Lin et al. · Cell · 1996 · 723 citations · Full text

Crystal Structure, Biochemistry, Natural Sciences +5

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

Joseph L. Kim, Kurt Morgenstern, James P Griffith et al. · Structure · 1998 · 611 citations · Full text

Virus Structure, Viral Replication, Crystal Structure +10

Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir

Christoph Sarrazin, Tara L. Kieffer, Doug J. Bartels et al. · Gastroenterology · 2007 · 611 citations

Hepatology, Hepatitis C, Patients Treated +11

Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease

Robert B. Perni, Susan J. Almquist, Randal A. Byrn et al. · Antimicrobial Agents and Chemotherapy · 2006 · 382 citations · Full text

Rows per page

1–5 of 31